Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1988;71(2):85-90.
doi: 10.1007/BF01245250.

Attenuation of MPTP-induced dopaminergic neurotoxicity by a serotonin uptake blocker

W J Brooks  1 , M F Jarvis, G C Wagner
Affiliations

Attenuation of MPTP-induced dopaminergic neurotoxicity by a serotonin uptake blocker

W J Brooks et al. J Neural Transm. 1988.

Abstract

Monoamine oxidase-B (MAO-B) has been determined to be the enzyme responsible for the conversion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) into its toxic metabolite 1-methyl-4-phenylpyridine ion (MPP+). Since this enzyme has been localized primarily in astrocytes and serotonergic neurons, it would appear that MPP+ is being produced outside the dopaminergic neurons. To investigate this possibility, the administration of MPTP was preceded by systemically administered fluoxetine. In keeping with its demonstrated ability to inhibit uptake into serotonergic neurons and serotonin uptake into astrocytes, fluoxetine pretreatment resulted in a significant attenuation of MPTP-induced depletions of striatal dopamine and serotonin concentration. These results support the extra-dopaminergic production of MPP+.

PubMed Disclaimer

References

    1. Neurosci Lett. 1985 Sep 6;59(3):259-64 - PubMed
    1. Science. 1984 Jun 29;224(4656):1451-3 - PubMed
    1. Science. 1985 May 17;228(4701):889-91 - PubMed
    1. Drug Alcohol Depend. 1984 May;13(3):225-34 - PubMed
    1. Proc Natl Acad Sci U S A. 1982 Oct;79(20):6385-9 - PubMed

Publication types

LinkOut - more resources